TC Biopharm (Holdings) Plc
TCBPY
$0.3548
$0.039812.64%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.56M | -15.06M | -14.58M | -10.83M | -7.39M |
| Total Depreciation and Amortization | 554.20K | 613.90K | 675.10K | 723.90K | 782.50K |
| Total Amortization of Deferred Charges | -- | 1.80K | 3.70K | 3.70K | 3.70K |
| Total Other Non-Cash Items | 1.50M | 1.69M | 1.89M | -4.05M | -8.42M |
| Change in Net Operating Assets | -2.59M | -872.50K | 873.60K | 1.53M | 1.92M |
| Cash from Operations | -16.09M | -13.63M | -11.14M | -12.62M | -13.10M |
| Capital Expenditure | -81.50K | -24.00K | 34.50K | 12.40K | -133.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.90K | -53.00K | -69.40K | -99.00K | -122.30K |
| Cash from Investing | -118.40K | -77.00K | -34.90K | -86.60K | -255.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.90M | 9.22M | 6.54M | 3.75M | 4.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -439.40K | 542.70K | 1.52M | 1.74M | 4.33M |
| Cash from Financing | 14.70M | 12.44M | 10.15M | 6.91M | 10.53M |
| Foreign Exchange rate Adjustments | -66.90K | -103.40K | -140.70K | -140.70K | -140.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.58M | -1.37M | -1.17M | -5.94M | -2.97M |